| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $51.1M | — | +1706.4% |
| R&D Expense | $12.6M | — | -75.1% |
| SG&A Expense | $12.7M | — | -28.0% |
| Operating Income | $30.0M | — | +145.8% |
| Pre-tax Income | $32.7M | — | +153.3% |
| Income Tax | $1K | — | +100.1% |
| Net Income | $32.7M | — | +154.4% |
| EPS (Basic) | $0.61 | — | +154.5% |
| EPS (Diluted) | $0.60 | — | +153.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $329.5M | +7.1% | -21.2% |
| Current Assets | $339.2M | +7.6% | -22.2% |
| Total Assets | $349.9M | +7.1% | -29.4% |
| Current Liabilities | $32.5M | -20.4% | -32.9% |
| Total Liabilities | $37.3M | -19.5% | -35.3% |
| Stockholders' Equity | $312.6M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $28.9M | — | +154.1% |
| Investing Cash Flow | $0 | — | +100.0% |
| Financing Cash Flow | -$6.9M | — | — |
| -28.6% |